Skip to content

Padua Prediction Score for VTE Risk in Thoracic Surgery Patients

Assessment of the Padua Prediction Score for Venous Thromboembolism Risk Stratification in Thoracic Surgery Patients: Insights From a Single-Center Cohort Study in Iraq

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06732726
Acronym
DVT
Enrollment
150
Registered
2024-12-13
Start date
2025-04-20
Completion date
2027-07-15
Last updated
2026-09-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

DVT - Deep Vein Thrombosis, VTE (Venous Thromboembolism)

Keywords

Padua Prediction Score (PPS)

Brief summary

The goal of this observational study is to assess the predictive accuracy of the Padua Prediction Score (PPS) for venous thromboembolism (VTE) risk in thoracic surgery patients. The study aims to answer the following question: Does the PPS provide a more accurate prediction of VTE risk? Participants will: Have their VTE risk assessed using the PPS during their hospital admission.

Detailed description

Venous thromboembolism (VTE) is a significant cause of morbidity and mortality, comprising conditions like deep vein thrombosis (DVT) and pulmonary embolism (PE). Hospitalized patients are particularly vulnerable to VTE due to factors such as prolonged immobility, surgical procedures, and preexisting comorbidities. To address this risk, tools like the Padua Prediction Score (PPS) have been developed. PPS is a validated scoring system that uses clinical and demographic criteria to categorize patients as high- or low-risk for VTE, allowing healthcare providers to tailor prophylactic measures accordingly. Although the Padua Prediction Score has been increasingly adopted in various healthcare settings, its applicability in Iraq remains understudied. There is limited local data on the prevalence of VTE, risk assessment practices and adherence to prophylaxis protocols, leaving a clear gap in the literature. This study aims to explore the utility and predictive accuracy of the Padua Prediction Score in the Iraqi healthcare context. By addressing this gap, the findings could help refine VTE prevention strategies, improve resource allocation, and ultimately reduce complications associated with this condition.

Interventions

None listed

Sponsors

Al-Nahrain University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who have undergone preoperative Padua Prediction Score assessment. * Inpatients with a hospital stay over 3 days * Written informed consent obtained from patients or their legal guardians. * Availability for postoperative follow-up to assess outcomes like LEVT development or related complications.

Exclusion criteria

* Preexisting LEVT or pulmonary embolism. * Severe Coagulopathy: Patients with inherited or acquired bleeding disorders (e.g., hemophilia, advanced liver disease). * receiving any anticoagulation therapy for any reason. * patients who did not undergo a postoperative D-dimer test. * Incomplete Data: missing essential clinical or laboratory data. * Pregnancy: pregnant women or those within six weeks postpartum. * Noncompliance: Patients unwilling or unable to adhere to study follow-up protocols.

Design outcomes

Primary

MeasureTime frameDescription
Incidence of Venous Thromboembolism (VTE) Episodes in PatientsIn-Hospital Phase (average of 10 days through discharge); Post-Discharge Follow-Up: Day 7, Day 15, and Day 30symptomatic or asymptomatic, confirmed by instrumental diagnostics.
Padua Prediction ScoreDay 1 preoperative (one day prior to surgery)A total score that ranges from 0 to 20. 4 or higher indicates a significant likelihood of developing VTE.

Secondary

MeasureTime frameDescription
Incidence of Symptomatic Pulmonary Embolism in PatientsIn-Hospital Phase (average of 10 days through discharge); Post-Discharge Follow-Up: Day 7, Day 15, and Day 30symptomatic pulmonary embolism confirmed by perfusion isotope scanning or CT pulmonary angiography.
Rate of Recurrent Deep Vein Thrombosis (DVT) in PatientsPost-Discharge Follow-Up: Day 7, Day 15, and Day 30A new episode of deep vein thrombosis occurs after the initial diagnosis with clinical symptoms (such as leg pain, swelling, redness, or tenderness) and is confirmed through instrumental diagnostics (e.g., ultrasound, CT venography, MRI).

Countries

Iraq

Contacts

CONTACTAbdul-Ilah R. Khamis
allaabed987@ced.nahrainuniv.edu.iq+9647838571013
STUDY_DIRECTORYaser aamer Eisa Alhaibi, Assistant professor

College Of Medicine - Nahrain University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 18, 2026